Purchase Order 36C24226P0588
- Not listed
- This federal contract award, with the ID 36C25925P0137, was made by the Veterans Integrated Service Network 19 (VISN 19), a division of the Department of Veterans Affairs (VA), to ASD Specialty Healthcare, LLC, a subsidiary of AmerisourceBergen Corporation. The $45,829.15 firm fixed-price purchase order is for the supply of the pharmaceutical product Adstiladrin, with a completion date of November 11, 2024. ASD Specialty Healthcare is an established federal contractor, with a history of...
- This is a $26,979.75 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to ASD Specialty Healthcare, LLC, a subsidiary of AmerisourceBergen Corporation. The contract is for the overnight delivery of pharmaceutical products, including specialty drugs, antiviral medications, and medical countermeasures, to support veteran healthcare services and other federal medical programs. ASD Specialty Healthcare has a...
- This is a purchase order from the Department of Veterans Affairs (VA) Veterans Health Administration to ASD Specialty Healthcare, LLC, a division of Amerisourcebergen Specialty Group, LLC and subsidiary of Amerisourcebergen Corporation. The $146,957.40 fixed-price contract is for the provision of specialty pharmaceutical products and distribution services to support veteran healthcare services. ASD Specialty Healthcare has a history of providing a range of medications, including cancer...
- This federal contract award, valued at $19,965.75, was made by the Department of Veterans Affairs (VA) to ASD Specialty Healthcare, LLC, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 1 bottle of the pharmaceutical product AMPYRA, a drug used to treat multiple sclerosis. This was a firm fixed-price purchase order without any set-aside designation, reflecting ASD Specialty Healthcare's status as a large, established pharmaceutical distributor. The award is...
- The Department of Veterans Affairs awarded a $183,316.60 firm fixed price purchase order to ASD Specialty Healthcare, LLC, a division of Amerisourcebergen Specialty Group, LLC. The contract has a total small business set aside designation. ASD Specialty Healthcare will provide 4 units of Adstiladrin drugs to support patient treatment at the Atlanta VA Health Care System, as specified in the sole source special notice issued by the agency. Each unit contains 2 doses of the pharmaceutical product,...
- This federal contract award was made by the Veterans Integrated Service Network 22, a civilian agency within the Department of Veterans Affairs (VA), to ASD Specialty Healthcare, LLC, a subsidiary of AmerisourceBergen Corporation. The $13,044.90 firm fixed-price purchase order is for the delivery of "EMERGENCY HUMATIN" and has a completion date of February 28, 2025. ASD Specialty Healthcare is a leading provider of specialty pharmaceutical distribution and technology solutions to...
- This federal contract award to ASD Specialty Healthcare, LLC, a subsidiary of AmerisourceBergen Corporation, involves the delivery of Remdesivir 100mg vials to the U.S. Department of Veterans Affairs (VA). The $77,850.00 firm fixed-price contract was awarded on December 30, 2020, with an ultimate completion date of January 31, 2021. The contract is not set aside for any specific business category. As a leading provider of specialty pharmaceutical distribution and technology solutions, ASD...
- This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration to ASD Specialty Healthcare, LLC, a division of Amerisourcebergen Specialty Group, LLC. The $140,130.00 firm fixed price purchase order is to provide COVID-19 treatment remdesivir. The contract has no set-aside designation and is tied to the national interest action code for the Coronavirus COVID-19 response. ASD Specialty Healthcare is known for specialty pharmaceutical distribution and...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,653.95 firm fixed price purchase order to ASD Specialty Healthcare, LLC for the delivery of BALVERSA 5MG tablets. ASD Specialty Healthcare will provide 28 count packages of the specified medication to support VHA's Veterans Integrated Service Network 2, which oversees healthcare facilities in parts of Texas and surrounding states. As a leading distributor of pharmaceuticals and medical supplies for government...
- This federal contract award, valued at $77,850.00, was made by the U.S. Department of Veterans Affairs (VA) to ASD Specialty Healthcare, LLC, a subsidiary of AmerisourceBergen. The contract is for the procurement of Veklury (remdesivir) 100 mg vials, an antiviral medication used for the treatment of COVID-19. The contract has an ultimate completion date of December 5, 2020, and was awarded on December 2, 2020 under a firm fixed-price purchase order. This award is not associated with a...
ASD Specialty Healthcare, LLC, a subsidiary of Cencora, Inc. (operating as AmerisourceBergen), received a firm fixed-price purchase order award from the Department of Veterans Affairs Veterans Integrated Service Network 2 for a pharmacy order of Adstiladrin, a specialty oncology medication. The contract, valued at approximately $46K, was awarded on April 21, 2026, with an ultimate completion date of July 21, 2026. The order will be fulfilled from the contractor's facility in Carrollton, Texas. No set-aside designation was applied to this award, reflecting the contractor's status as an established large business competing on a full and open basis. ASD Specialty Healthcare has established itself as a critical supplier of specialty pharmaceutical products to the VA and other federal agencies, with over $100 million in prime contract awards since 2021, primarily for emergency pharmaceutical procurement and specialty medications including oncology treatments, antivirals, and antimicrobial agents. This award is consistent with the company's ongoing role in supporting federal healthcare systems and the VA's pharmaceutical supply requirements. The transaction represents a single purchase order for a specific medication rather than a larger indefinite delivery vehicle; however, the parent company, Cencora, Inc., maintains a significant $999.99 billion indefinite delivery contract with the Defense Logistics Agency for comprehensive pharmaceutical and medical supply distribution through December 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.0k | 4/20/26 |